patient-navigation
(4)
Leal Health
Leal Health (formerly TrialJectory) is an AI-powered treatment decision-support platform that gives cancer patients and their oncologists an unbiased, single point of access to FDA-approved therapies and clinical trials matched to a patient's exact diagnosis. Founded in 2017 and headquartered in New York, the company built a patented, generative-AI engine that reads thousands of trials and treatment options, then matches patients in a roughly two-minute intake. It has facilitated millions of treatment matches across 22+ cancer types, is free for patients and clinicians, and earns revenue from biopharma partners and health plans. In February 2026 Leal Health was acquired by Nexus Precision Health.
Fidari
Fidari is a healthtech company building digital infrastructure for oncology navigation. Its software plugs into existing EHR systems via FHIR/HL7 to automate patient-navigation workflows, capture navigation billing revenue, and connect cancer patients to supportive and ancillary services through an integrated marketplace. Founded in 2023 and led by second-time healthcare founder Othman Ouenes, Fidari pairs AI-driven triage with human navigators to support patients from diagnosis through survivorship, while generating research-ready real-world data for life-sciences partners.
Manta Cares
Manta Cares is a San Francisco-based digital health company redesigning the cancer experience for patients and caregivers. Founded by breast cancer survivor Samira Daswani, it offers a free, HIPAA-compliant, AI-enabled platform - featuring subway-style Cancer Maps, a symptom and appointment planner, and expert-reviewed resources vetted by 100+ oncologists - that turns the chaotic cancer journey into a navigable path. The company launched publicly in November 2025 with an oversubscribed $5.4M seed round led by Pear VC and Sozo Ventures.
Diagnostic Robotics
Diagnostic Robotics is an AI healthcare company building medical-grade triage and clinical-prediction software for health plans and providers. Its models, trained on tens of billions of claims data points and nearly 100 million patient visits, forecast avoidable ER visits, congestive heart failure deterioration and serious mental illness, then steer patients into the right care pathway. Founded in 2017 by Kira Radinsky, Jonathan (Yonatan) Amir and Moshe Shoham, the company is a Mayo Clinic Platform portfolio company and closed a $45M Series B in 2022.